Oncoinvent ASA banner
O

Oncoinvent ASA
OSE:ONCIN

Watchlist Manager
Oncoinvent ASA
OSE:ONCIN
Watchlist
Price: 46.72 NOK -0.5% Market Closed
Market Cap: kr209.3m

Oncoinvent ASA
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Oncoinvent ASA
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
O
Oncoinvent ASA
OSE:ONCIN
Other Items
kr3.8m
CAGR 3-Years
3%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Photocure ASA
OSE:PHO
Other Items
kr12.2m
CAGR 3-Years
79%
CAGR 5-Years
48%
CAGR 10-Years
N/A
V
Vistin Pharma ASA
OSE:VISTN
Other Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
Navamedic ASA
OSE:NAVA
Other Items
-kr186.6m
CAGR 3-Years
-100%
CAGR 5-Years
-59%
CAGR 10-Years
-23%
S
SoftOx Solutions AS
OSE:SOFTX
Other Items
kr10.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Oncoinvent ASA
Glance View

Market Cap
209.3m NOK
Industry
Pharmaceuticals

Oncoinvent ASA engages in the development of cancer treatment products. The company is headquartered in Oslo, Oslo and currently employs 34 full-time employees. The company went IPO on 2024-12-13. The firm is engaged in the development of alpha-emitting radiotherapeutics that provide better treatment options to cancer patients. The firm offers Radspherin, which is alpha-emitting radioactive microsphere therapy designed for the treatment of metastatic cancers in body cavities. The product candidate is a suspension of inorganic microspheres labelled with an alpha-emitting radioisotope for local administration. More specifically it consists of with calcium carbonate micro particles labelled with the radioisotope Radium-224d. The therapeutic goal is to treat residual micro metastases remaining after surgery in intracavitary surfaces and liquid without subjecting deeper regions of organs and tissues to harmful radiation doses.

ONCIN Intrinsic Value
77.58 NOK
Undervaluation 40%
Intrinsic Value
Price kr46.72
O

See Also

What is Oncoinvent ASA's Other Items?
Other Items
3.8m NOK

Based on the financial report for Jun 30, 2025, Oncoinvent ASA's Other Items amounts to 3.8m NOK.

What is Oncoinvent ASA's Other Items growth rate?
Other Items CAGR 5Y
10%

Over the last year, the Other Items growth was 30%. The average annual Other Items growth rates for Oncoinvent ASA have been 3% over the past three years , 10% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett